ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis
Clinical trial NCT04695080 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04695080
- Sponsor
- Queen Mary University of London
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-25
- Primary completion
- 2027-12-31
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.